Dexcel Pharma's facilities comprise a total of 467,000 square feet – 43,380 square meters – at 3 locations, including:

• An expanded facility in Or Akiva.
• A new, state of the art, 5-floor gravity feed, paperless, electronic manufacturing plant of tablets/capsules in Yokneam.
• A smaller manufacturing unit in Jerusalem.

Dexcel Pharma manufactured 3.9 billion tablets/capsules in 2009, with 5.4 billion forecast for 2010.

Dexcel Pharma employs cutting-edge, computer-controlled technology – including electronic batch recording –  facilitating optimization of production and reduction in human error.

Dexcel Pharma’s manufacturing facilities and their operations are approved by the US FDA, UK MHRA and the German authorities, and meet or exceed all US and EU cGMP standards.

Dexcel Pharma offers flexible and responsive service, on-time delivery, competitive pricing, efficient technical transfer and inventory coverage, and global supply chain management services.

Print

© All Rights Reserved to Dexcel Ltd.

Another site by | Graphic Design OneGroup | Developed by CodeOasis |